hoe 33342 has been researched along with Alloxan Diabetes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, DS; Han, SH; Jung, DS; Kang, SW; Kim, DK; Kwak, SJ; Lee, JE; Lee, SH; Li, JJ; Moon, SJ; Nam, BY; Ryu, DR; Yoo, TH | 1 |
Alder, VA; Ben-nun, J; Constable, IJ | 1 |
2 other study(ies) available for hoe 33342 and Alloxan Diabetes
Article | Year |
---|---|
Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Animals; Apoptosis; Apoptosis Regulatory Proteins; Benzimidazoles; Blotting, Western; Caspase 3; Cell Count; Cells, Cultured; Cytochrome P-450 CYP11B2; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique; Fluorescent Dyes; In Situ Nick-End Labeling; Kidney; Kidney Glomerulus; Male; Podocytes; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Retinal microvascular patency in the diabetic rat.
Topics: Alloxan; Animals; Benzimidazoles; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fluorescent Dyes; Galactose; Male; Microcirculation; Rats; Rats, Wistar; Retinal Vessels; Streptozocin; Time Factors; Vascular Patency | 2004 |